ResMed
583 hedge funds and large institutions have $19.6B invested in ResMed in 2020 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 228 increasing their positions, 205 reducing their positions, and 65 closing their positions.
35% more capital invested
Capital invested by funds: $14.5B → $19.6B (+$5.11B)
11% more repeat investments, than reductions
Existing positions increased: 228 | Existing positions reduced: 205
2.56% more ownership
Funds ownership: 68.2% → 70.76% (+2.6%)
6% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 65
0% less funds holding
Funds holding: 584 → 583 (-1)
7% less funds holding in top 10
Funds holding in top 10: 15 → 14 (-1)
28% less call options, than puts
Call options by funds: $68.8M | Put options by funds: $96.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$141M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$67.4M |
| 3 |
Baird Financial Group
Milwaukee,
Wisconsin
|
+$61M |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$57.1M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$52.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$48.8M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$32.9M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$29.2M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$25.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$22.5M |
RMD Hedge Fund Activity: Q2 2020 in Review
583 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q2 2020, worth a combined $19.6B — up 35% from $14.5B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new RMD positions and 65 closed out — a net gain of 4 holders — while 228 added to existing stakes and 205 trimmed.
The largest buyer was BlackRock, adding an estimated $141M. The largest seller was Fidelity Investments, cutting an estimated $48.8M.
- 583 institutional investors held ResMed (RMD) as of Q2 2020, down from 584 in Q1 2020.
- Funds reported $19.6B of ResMed stock for Q2 2020, up 35% quarter-over-quarter.
- 69 funds opened new ResMed positions in Q2 2020 and 65 closed out, a net change of +4 holders.
- The largest ResMed buyer in Q2 2020 was BlackRock, an estimated $141M added.
- The largest ResMed seller in Q2 2020 was Fidelity Investments, an estimated $48.8M sold.
Based on aggregated 13F filings for Q2 2020.